NEA 13 GP, Ltd's Net Worth
$1.67 Billion
Who is NEA 13 GP, Ltd?
NEA 13 GP, Ltd has an estimated net worth of $1.67 Billion. This is based on reported shares across multiple companies, which include Sagimet Biosciences Inc., Cloudflare, Inc., RHYTHM PHARMACEUTICALS, INC., TESARO, Inc., Workday, Inc., Care.com Inc, Millennial Media Inc., AEROHIVE NETWORKS, INC, BuzzFeed, Inc., Sprout Social, Inc., Clovis Oncology, Inc., BOX INC, Coursera, Inc., Dermira, Inc., PhaseBio Pharmaceuticals Inc, GLYCOMIMETICS INC, Epizyme, Inc., MINERVA SURGICAL INC, Roka BioScience, Inc., Omthera Pharmaceuticals, Inc., Ra Pharmaceuticals, Inc., and CVENT INC.
SEC CIK
NEA 13 GP, Ltd's CIK is 0001460751
Past Insider Trading and Trends
2014 was NEA 13 GP, Ltd's most active year for acquiring shares with 19 total transactions. NEA 13 GP, Ltd's most active month to acquire stocks was the month of September. 2014 was NEA 13 GP, Ltd's most active year for disposing of shares, totalling 24 transactions. NEA 13 GP, Ltd's most active month to dispose stocks was the month of September. 2016 saw NEA 13 GP, Ltd paying a total of $39,405,647.57 for 11,034,334 shares, this is the most they've acquired in one year. In 2019 NEA 13 GP, Ltd cashed out on 65,229,034 shares for a total of $726,077,850.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Cloudflare, Inc. (NET) Snapshot price: $82.35
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
| 2.76M |
Nov 11
| |||
Form 4
| -31.92% | -1.30M |
—
|
—
| 2.76M |
Aug 7
| |||
Form 4
|
—
|
0
|
—
|
—
| 4.06M |
May 19
| |||
Form 4
|
∞
| 4.06M |
—
|
—
| 4.06M |
Sep 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Sagimet Biosciences Inc. (SGMT) Snapshot price: $6.325
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -22.08% | -850.00K |
—
|
—
| 3M |
Jan 29
| |||
Form 4
| +10,119.44% | 3.81M |
$13.65 | -$10,592.00 | 3.85M |
Jul 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Sprout Social, Inc. (SPT) Snapshot price: $60.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -44.78% | -2.50M |
—
|
—
| 3.08M |
Nov 13
| |||
Form 4
| -38.14% | -3.44M |
$27.50 | -$94,650,765.00 | 5.58M |
Aug 17
| |||
Form 4
|
∞
| 9.02M |
—
|
—
| 9.02M |
Dec 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PhaseBio Pharmaceuticals Inc (PHASQ) Snapshot price: $0.0002
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -26.86% | -1.78M |
$0.15 | -$262,264.02 | 4.86M |
Oct 25
| |||
Form 4
|
∞
| 6.64M |
$5.00 |
—
| 6.64M |
Oct 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
GLYCOMIMETICS INC (GLYC) Snapshot price: $3.17
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.09M |
$8.00 |
—
| 4.09M |
Jan 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |